Paediatric rheumatology: Corticosteroids as primary therapy in Kawasaki disease

Rebecca Reindel, Stanford T Shulman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Coronary artery aneurysms affect a substantial proportion of patients with Kawasaki disease, especially when standard therapy fails. Adjunctive primary corticosteroid treatment reduces inflammation and might reduce the incidence of coronary artery disease in a subset of patients at high risk of this comorbidity, but reliably identifying such individuals is a challenge.

Original languageEnglish (US)
Pages (from-to)373-374
Number of pages2
JournalNature Reviews Rheumatology
Volume8
Issue number7
DOIs
StatePublished - Jul 1 2012

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'Paediatric rheumatology: Corticosteroids as primary therapy in Kawasaki disease'. Together they form a unique fingerprint.

Cite this